Avanir Pharmaceuticals Inc., an Aliso Viejo-based drug maker, said Thursday that it raised $10.6 million through a stock sale.
Avanir said it sold 4.5 million shares of its stock.
The company said it would use the money to fund the continuing development and commercialization of its Zenvia drug candidate for controlling uncontrollable fits of crying or laughter, and for general and administrative expenses.
Earlier this month, Avanir said that Zenvia had met certain goals in a late-stage clinical trial and plans to submit a response to the Food and Drug Administration about the drug early next year.
Back in 2006, the FDA said Zenvia could be approved, but said it was concerned that one of its active ingredients might lead to heart problems.
Regulators asked for more testing, and Avanir eventually started testing with a revised formulation of Zenvia.
